 Description: Tigowin is an antibiotic containing the active ingredient tigecycline. It is a member of the glycylcycline class of antibiotics and is typically administered as an intravenous infusion. It is used to treat serious bacterial infections and is often reserved for critically ill patients or when other antibiotics are not suitable.

 Indication: Tigowin (tigecycline) is indicated for the treatment of various bacterial infections, including:

• Complicated skin and skin structure infections.
• Complicated intra-abdominal infections.
• Community-acquired bacterial pneumonia.

It is important to note that it is not effective against viral infections like the common cold or flu.

 Mechanism of Action: Tigecycline works by inhibiting bacterial protein synthesis. It binds to the 30S ribosomal subunit of the bacteria, which prevents amino-acyl tRNA molecules from entering the A site of the ribosome. This action stops the growth of the peptide chain, effectively halting the bacteria’s ability to produce the essential proteins it needs to survive and multiply.